Literature DB >> 8750377

Financial effect of clinical decisions: case study of a dialysis center.

E A Balas1, L L Hicks, J V Stone, L P Ponferrada, D A West.   

Abstract

The purpose of this study was to specify the financial effect of clinical decisions in a dialysis center. A consecutive sample of 14,343 outpatient hemodialysis treatments (OHD), 16,111 continuous ambulatory peritoneal dialysis (CAPD), and 4,513 chronic cycler-assisted peritoneal dialysis (CCPD) days of treatment was analyzed. An activity-based cost calculation method was applied to the analysis of alternative treatments (service bundles). The weekly cost of OHD was higher ($338 versus $241/$242), and the contribution margin (reimbursement minus total cost) of CAPD/CCPD was much greater ($.48 versus $148/$147 per patient week). Clinical decision-making had an influence on less than 6.8% of OHD and 45.4%/46.6% of CAPD/CCPD related expenses. In comparison to activity-based cost calculation, conventional methods overestimated the overhead expense of CAPD by 3-48%. This study documented that most cost control opportunities reside in the usual process of care and less can be influenced by a direct interference with the patient-physician contacts. Paying for 1 week of renal replacement (capitation) could simplify the process of reimbursement and cost tracking.

Entities:  

Mesh:

Year:  1995        PMID: 8750377     DOI: 10.1007/bf02260850

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  24 in total

1.  [Financial impact of anemia in patients with chronic renal insufficiency undergoing hemodialysis at centers].

Authors:  P Rousseau
Journal:  Nephrologie       Date:  1990

2.  The orthopaedic critical path.

Authors:  E M Metcalf
Journal:  Orthop Nurs       Date:  1991 Nov-Dec       Impact factor: 0.913

3.  Geographic variation in the incidence of treated end-stage renal disease.

Authors:  B Foxman; L H Moulton; R A Wolfe; K E Guire; F K Port; V M Hawthorne
Journal:  J Am Soc Nephrol       Date:  1991-12       Impact factor: 10.121

4.  A cost effectiveness analysis of the treatment of end stage renal failure.

Authors:  B E Croxson; T Ashton
Journal:  N Z Med J       Date:  1990-04-25

Review 5.  Clinical economics. A guide to the economic analysis of clinical practices.

Authors:  J M Eisenberg
Journal:  JAMA       Date:  1989-11-24       Impact factor: 56.272

6.  Predicting treatment costs and life expectancy for end-stage renal disease.

Authors:  P V Stange; A T Sumner
Journal:  N Engl J Med       Date:  1978-02-16       Impact factor: 91.245

7.  The costs of domiciliary maintenance haemodialysis. A comparison with alternative renal replacement regimens.

Authors:  J H Stewart; N D Topp; S Martin; E Schawrowas; Y Flaus; A G Sheil; J F Mahony
Journal:  Med J Aust       Date:  1973-01-27       Impact factor: 7.738

8.  The effect on test ordering of informing physicians of the charges for outpatient diagnostic tests.

Authors:  W M Tierney; M E Miller; C J McDonald
Journal:  N Engl J Med       Date:  1990-05-24       Impact factor: 91.245

9.  Cost-effective care of end-stage renal disease: a billion dollar question.

Authors:  S D Roberts; D R Maxwell; T L Gross
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

10.  Reuse of haemodialysis equipment: convenience and cost effectiveness.

Authors:  H K Banester; R D Driscoll; R N Greenwood; W R Cattell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.